angiodynamics.com (ANGO): Rentabilitas operasi

AngioDynamics, Inc. (ANGO) is pivoting away from low-cost consumables to avoid pricing pressure. This margin-expansion strategy is linked to the implementation of NanoKnife AI systems for cancer treatment. Manufacturing capacities in the UK and US ensure the uninterrupted production of instruments. The operating profitability history clearly demonstrates profit dynamics, and -6.00 reflects the latest value of the metric.
Rincian analitis lan laporan data perusahaan angiodynamics.com (ANGO)

The operating margin of AngioDynamics, Inc. (ANGO) reflects the production efficiency of medical systems before accounting for financial expenses and taxes. This metric measures the share of profit from core operations relative to total sales, which is critical for assessing profitability. The current operating income as a percentage of revenue stands at -6.00. The trend of this indicator reveals the business's vulnerability to supply chain disruptions and sanction-related restrictions in target markets. Margin stability confirms the company's fundamental resilience to geopolitical shocks.